Shen H - Search Results

1

Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis.

Gao W, Yu Y, Cao H, Shen H, Li X, Pan S, Shu Y. Gao W, et al. Among authors: shen h. Biomed Pharmacother. 2010 Jul;64(6):399-408. doi: 10.1016/j.biopha.2010.01.018. Epub 2010 Feb 25. Biomed Pharmacother. 2010. PMID: 20363096

2

Genomic alterations in lung adenocarcinomas detected by multicolor fluorescence in situ hybridization and comparative genomic hybridization.

Shen H, Zhu Y, Wu YJ, Qiu HR, Shu YQ. Shen H, et al. Cancer Genet Cytogenet. 2008 Mar;181(2):100-7. doi: 10.1016/j.cancergencyto.2007.11.012. Cancer Genet Cytogenet. 2008. PMID: 18295661

3

Multicolor fluorescence in situ hybridization and comparative genomic hybridization reveal molecular events in lung adenocarcinomas and squamous cell lung carcinomas.

Shen H, Gao W, Wu YJ, Qiu HR, Shu YQ. Shen H, et al. Biomed Pharmacother. 2009 Jul;63(6):396-403. doi: 10.1016/j.biopha.2008.08.010. Epub 2008 Sep 16. Biomed Pharmacother. 2009. PMID: 18848758

4

Involvement of mTOR and survivin inhibition in tamoxifen-induced apoptosis in human hepatoblastoma cell line HepG2.

Guo R, Wang T, Shen H, Ge HM, Sun J, Huang ZH, Shu YQ. Guo R, et al. Among authors: shen h. Biomed Pharmacother. 2010 Apr;64(4):249-53. doi: 10.1016/j.biopha.2009.06.007. Epub 2009 Oct 22. Biomed Pharmacother. 2010. PMID: 19931998

5

Combined tamoxifen and gefitinib in non-small cell lung cancer shows antiproliferative effects.

Shen H, Yuan Y, Sun J, Gao W, Shu YQ. Shen H, et al. Biomed Pharmacother. 2010 Feb;64(2):88-92. doi: 10.1016/j.biopha.2009.06.010. Epub 2009 Oct 23. Biomed Pharmacother. 2010. PMID: 20005069

6

MiR-21 overexpression in human primary squamous cell lung carcinoma is associated with poor patient prognosis.

Gao W, Shen H, Liu L, Xu J, Xu J, Shu Y. Gao W, et al. Among authors: shen h. J Cancer Res Clin Oncol. 2011 Apr;137(4):557-66. doi: 10.1007/s00432-010-0918-4. Epub 2010 May 28. J Cancer Res Clin Oncol. 2011. PMID: 20508945

7

[Clinical Study of Erlotinib in the Treatment of Patients with Advanced Stage Non-small Cell Lung Cancer.].

Wang T, Sun J, Gao W, Shen H, Li X, Yin Y, Shu Y, Guo R. Wang T, et al. Among authors: shen h. Zhongguo Fei Ai Za Zhi. 2009 Dec 20;12(12):1287-90. doi: 10.3779/j.issn.1009-3419.2009.12.12. Zhongguo Fei Ai Za Zhi. 2009. PMID: 20723385 Free article. Chinese.

8

Restoration of gefitinib efficacy following chemotherapy in a patient with metastatic non-small cell lung cancer.

Li XD, Geng YT, Wu CP, Shen H, Sun J, Shu YQ, Yin YM. Li XD, et al. Among authors: shen h. Onkologie. 2010;33(8-9):466-9. doi: 10.1159/000319109. Epub 2010 Jul 27. Onkologie. 2010. PMID: 20838064

9

The regimen of gemcitabine and cisplatin combined with radio frequency hyperthermia for advanced non-small cell lung cancer: a phase II study.

Shen H, Li XD, Wu CP, Yin YM, Wang RS, Shu YQ. Shen H, et al. Int J Hyperthermia. 2011;27(1):27-32. doi: 10.3109/02656736.2010.500645. Epub 2010 Sep 21. Int J Hyperthermia. 2011. PMID: 20858088 Free article. Clinical Trial.

10

Paclitaxel based vs oxaliplatin based regimens for advanced gastric cancer.

Li XD, Shen H, Jiang JT, Zhang HZ, Zheng X, Shu YQ, Wu CP. Li XD, et al. Among authors: shen h. World J Gastroenterol. 2011 Feb 28;17(8):1082-7. doi: 10.3748/wjg.v17.i8.1082. World J Gastroenterol. 2011. PMID: 21448363 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14,491 results

Search Page

Filters